March 05 2025
The NRG Oncology Lung Cancer Committee represents one of NRG Oncology’s seven Disease Site Committees. The Disease Site Committees develop, conduct, monitor, and report results of clinical trials and translational science projects aimed at improving outcomes (survival and quality of life) for cancer patients. These committees review and prioritize protocol concepts, and present them to the NRG Oncology Research Strategy Committee. Committee Chairs aide in the cohesive management and conduct of NRG Oncology activities, including;
- Providing a framework for collaborative participation designed to support the development and/or conduct of timely, feasible, and innovative clinical trials and the publication of findings.
- Monitoring the developing, active, and yet-to-be published studies or committee activities. Prioritizes activities, allocates committee resources, and communicates priorities across the committee.
- Delegating effectively; reassigning duties where necessary to meet timelines or deadlines.
- Ensuring Committee members are appointed on a regular basis and remain engaged with the Committee with opportunities for input into developing concepts, protocols, or discussions of new directions.
- Supporting an inclusive and engaged committee, supportive of broad input, timely engagement of liaisons where appropriate, and establishing operating norms for the committee.
- Supporting the mentoring and training of young and/or new investigators who are interested in working with NRG Oncology.
- Serving as an advocate for NRG Oncology in all affairs.
- Engaging across NRG Oncology; liaising with other committee chairs, participating in NRG Oncology meetings, keeping NRG Oncology Group Chairs informed of trends, changes, or concerns of note.
- Collaborating with NRG Oncology leadership and members to write and edit scientific grants to support NRG Oncology research activities, including the NRG Oncology core grant.
- Supporting the conduct of activities that are compliant with regulations, NRG Policies and Procedures, and practices that ensure potential conflicts are disclosed and managed.
NRG Oncology Committee Chairs must be at an NRG Oncology Member Institution and eligible to receive federal funding. Nominal funds from federal grants to offset related effort and travel to NRG Oncology meetings is provided. Committee Chairs are appointed by the NRG Oncology Group Chairs for a six-year term, renewable once.
Applicants for the position should forward a signed and dated cover letter (on institutional letterhead) addressing specific interests and qualifications for the role as well as your NIH biosketch to committee-nominations@nrgoncology.org.In addition, candidates are required to have either completed the NRG Oncology Member Information Form or have formally elected to opt-out. Information about the form is posted on the NRG Oncology website at https://www.nrgoncology.org/NRG-Member-Info. The deadline for the application submission is April 7, 2025. If you have questions about the position, forward those to the same email and we will have an appropriate party get back to you.